Literature DB >> 34150136

Dynamics of heart rate variability in patients with type 2 diabetes mellitus during spinal anesthesia using dexmedetomidine.

Liying Ye1, Bo Dai2, Zheyou Wu3, Ying Hu1.   

Abstract

Objective The aim of this study was to investigate the heart rate variability (HRV) in patients with Type 2 diabetes mellitus (T2DM) who underwent spinal anesthesia using dexmedetomidine for lower limb surgery.
METHODS: T2DM patients were divided into two groups, namely the controlled group (HbA1c < 7%) and the uncontrolled group (HbA1c > 7%) according to the glycosylated hemoglobin (HbA1c) level, and patients with non-T2DM as the normal group, 30 cases in each group. The HRV, including low-frequency (LF) power, high-frequency (HF) power, total power (TP) and LF/HF ratio, was measured 10 min before spinal anesthesia (T0) and 10 min (T1), 20 min (T2) and 30 min (T3) after spinal anesthesia with dexmedetomidine.
RESULTS: We observed that TP, LF, and HF power in the uncontrolled group were remarkably lower than that in the other two groups at T0 (P < 0.05). In the controlled group, the LF power dropped markedly at T1-2 than the normal group. The LF power in the uncontrolled group did not show significant change at all time points, but was significantly lower than the level in the controlled group at T1-3. The HF power in the three groups did not alter markedly at different time points, but the HF power in the uncontrolled group was markedly lower than that in the normal group and the controlled group. In all three groups, the LF/HF ratio dropped markedly at T1-3 with no markedly difference between the groups. The heart rhythms in the three groups showed a decrease trend after spinal anesthesia with no markedly difference between the groups. The SBP and DBP at T1-3 in the three groups were markedly lower than that at T0, and the systolic blood pressure (SBP) and diastolic blood pressure (DBP) at T1-3 in the uncontrolled group were markedly higher than those in the normal group and the controlled group.
CONCLUSION: Spinal anesthesia with dexmedetomidine affects autonomic nerve function in patients whose glycemic control is better during the lower limb surgery in T2DM patients, but has no significant effect on patients who fail to do so. For such patients, spinal anesthesia can result in a markedly increase in SBP and DBP. AJTR
Copyright © 2021.

Entities:  

Keywords:  Type 2 diabetes mellitus (T2DM); glycemic control; glycosylated hemoglobin; heart rate variability (HRV); spinal anesthesia

Year:  2021        PMID: 34150136      PMCID: PMC8205755     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  21 in total

Review 1.  Neonatal management of pregnancy complicated by diabetes.

Authors:  Fauzia Mohsin; Shareen Khan; Md Abdul Baki; Bedowra Zabeen; Kiswhar Azad
Journal:  J Pak Med Assoc       Date:  2016-09       Impact factor: 0.781

2.  Relative burst amplitude of muscle sympathetic nerve activity is an indicator of altered sympathetic outflow in chronic anxiety.

Authors:  Seth W Holwerda; Rachel E Luehrs; Allene L Gremaud; Nealy A Wooldridge; Amy K Stroud; Jess G Fiedorowicz; Francois M Abboud; Gary L Pierce
Journal:  J Neurophysiol       Date:  2018-03-14       Impact factor: 2.714

3.  Decreased heart rate variability may predict the progression of carotid atherosclerosis in type 2 diabetes.

Authors:  Anders Gottsäter; Asa Rydén Ahlgren; Soumia Taimour; Göran Sundkvist
Journal:  Clin Auton Res       Date:  2006-05-12       Impact factor: 5.625

4.  Effects of Coexistence Hypertension and Type II Diabetes on Heart Rate Variability and Cardiorespiratory Fitness.

Authors:  Daniela Bassi; Ramona Cabiddu; Renata G Mendes; Natália Tossini; Vivian M Arakelian; Flávia C R Caruso; José C Bonjorno Júnior; Ross Arena; Audrey Borghi-Silva
Journal:  Arq Bras Cardiol       Date:  2018-07       Impact factor: 2.000

5.  Moderate intensity exercise improves heart rate variability in obese adults with type 2 diabetes.

Authors:  Rajesh Kumar Goit; Bhawana Neupane Pant; Mukesh Kumar Shrewastwa
Journal:  Indian Heart J       Date:  2017-10-04

6.  Relationship between autonomic nervous system function and continuous interstitial glucose measurement in patients with type 2 diabetes.

Authors:  Stavroula Kalopita; Stavros Liatis; Petros Thomakos; Ioannis Vlahodimitris; Chryssoula Stathi; Nicholas Katsilambros; Nicholaos Tentolouris; Konstantinos Makrilakis
Journal:  J Diabetes Res       Date:  2014-08-03       Impact factor: 4.011

Review 7.  Heart rate variability in type 2 diabetes mellitus: A systematic review and meta-analysis.

Authors:  Thomas Benichou; Bruno Pereira; Martial Mermillod; Igor Tauveron; Daniela Pfabigan; Salwan Maqdasy; Frédéric Dutheil
Journal:  PLoS One       Date:  2018-04-02       Impact factor: 3.240

8.  Heart rate variability based on risk stratification for type 2 diabetes mellitus.

Authors:  Julia Silva-E-Oliveira; Pâmela Marina Amélio; Isabela Lopes Laguardia Abranches; Dênis Derly Damasceno; Fabianne Furtado
Journal:  Einstein (Sao Paulo)       Date:  2017 Apr-Jun

9.  Normalization of heart rate variability with taurine and meldonium complex in post-infarction patients with type 2 diabetes mellitus.

Authors:  Juliia Belikova; Victor Lizogub; Andrii Kuzminets; Iryna Lavrenchuk
Journal:  J Med Life       Date:  2019 Jul-Sep

10.  Heart Rate Variability and Cardiac Autonomic Dysfunction: Prevalence, Risk Factors, and Relationship to Arterial Stiffness in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.

Authors:  Amy S Shah; Laure El Ghormli; Mary Ellen Vajravelu; Fida Bacha; Ryan M Farrell; Samuel S Gidding; Lorraine E Levitt Katz; Jeanie B Tryggestad; Neil H White; Elaine M Urbina
Journal:  Diabetes Care       Date:  2019-09-09       Impact factor: 19.112

View more
  1 in total

Review 1.  Amelioration of myocardial ischemia/reperfusion injury in diabetes: A narrative review of the mechanisms and clinical applications of dexmedetomidine.

Authors:  Meng Sun; Rong Wang; Rui Xia; Zhengyuan Xia; Zhilin Wu; Tingting Wang
Journal:  Front Pharmacol       Date:  2022-08-31       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.